{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T13:48:03Z","timestamp":1777124883883,"version":"3.51.4"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T00:00:00Z","timestamp":1740700800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T00:00:00Z","timestamp":1740700800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neurol Belg"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1007\/s13760-025-02752-9","type":"journal-article","created":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T01:03:42Z","timestamp":1740704622000},"page":"727-735","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Expression levels of protein inhibitor of activated STAT (PIAS) family genes in Parkinson\u2019s disease patients: results from a case-control study"],"prefix":"10.1007","volume":"125","author":[{"given":"Fariba Akbari","family":"Gavabari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohsen","family":"Rastegari-Pouyani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saeid","family":"Afshar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehrdokht","family":"Mazdeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Armin","family":"Bahramian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siamak","family":"Shahidi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elahe","family":"Talebi-ghane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahsa","family":"Chalabi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad Mahdi","family":"Eftekharian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,2,28]]},"reference":[{"key":"2752_CR1","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1146\/annurev-pathmechdis-031521-034145","volume":"18","author":"H Ye","year":"2023","unstructured":"Ye H et al (2023) Genetics and pathogenesis of Parkinson\u2019s syndrome. Annu Rev Pathol 18:95\u2013121","journal-title":"Annu Rev Pathol"},{"issue":"5","key":"2752_CR2","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/S1474-4422(21)00030-2","volume":"20","author":"E Tolosa","year":"2021","unstructured":"Tolosa E et al (2021) Challenges in the diagnosis of Parkinson\u2019s disease. Lancet Neurol 20(5):385\u2013397","journal-title":"Lancet Neurol"},{"key":"2752_CR3","doi-asserted-by":"crossref","unstructured":"Pajares M et al (2020) Inflammation in Parkinson\u2019s disease: mechanisms and therapeutic implications. Cells, 9(7):1687","DOI":"10.3390\/cells9071687"},{"issue":"1","key":"2752_CR4","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s12264-022-00934-6","volume":"39","author":"HN Costa","year":"2023","unstructured":"Costa HN et al (2023) Parkinson\u2019s disease: A multisystem disorder. Neurosci Bull 39(1):113\u2013124","journal-title":"Neurosci Bull"},{"key":"2752_CR5","doi-asserted-by":"publisher","first-page":"1376633","DOI":"10.3389\/fonc.2024.1376633","volume":"14","author":"X Li","year":"2024","unstructured":"Li X et al (2024) PIAS family in cancer: from basic mechanisms to clinical applications. Front Oncol 14:1376633","journal-title":"Front Oncol"},{"issue":"8","key":"2752_CR6","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/gene.2010.35","volume":"11","author":"JK Morales","year":"2010","unstructured":"Morales JK et al (2010) Mast cell homeostasis and the JAK-STAT pathway. Genes Immun 11(8):599\u2013608","journal-title":"Genes Immun"},{"issue":"2","key":"2752_CR7","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1038\/sj.cr.7310027","volume":"16","author":"K Shuai","year":"2006","unstructured":"Shuai K (2006) Regulation of cytokine signaling pathways by PIAS proteins. Cell Res 16(2):196\u2013202","journal-title":"Cell Res"},{"key":"2752_CR8","doi-asserted-by":"publisher","first-page":"2392","DOI":"10.3389\/fimmu.2018.02392","volume":"9","author":"GJ Niu","year":"2018","unstructured":"Niu GJ et al (2018) Protein inhibitor of activated STAT (PIAS) negatively regulates the JAK\/STAT pathway by inhibiting STAT phosphorylation and translocation. Front Immunol 9:2392","journal-title":"Front Immunol"},{"issue":"7","key":"2752_CR9","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1158\/0008-5472.CAN-16-2958","volume":"77","author":"A Rabellino","year":"2017","unstructured":"Rabellino A, Andreani C, Scaglioni PP (2017) The role of PIAS SUMO E3-Ligases in Cancer. Cancer Res 77(7):1542\u20131547","journal-title":"Cancer Res"},{"issue":"1","key":"2752_CR10","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12964-017-0177-y","volume":"15","author":"F Seif","year":"2017","unstructured":"Seif F et al (2017) The role of JAK-STAT signaling pathway and its regulators in the fate of T helper cells. Cell Commun Signal 15(1):23","journal-title":"Cell Commun Signal"},{"issue":"8","key":"2752_CR11","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1038\/nri1667","volume":"5","author":"K Shuai","year":"2005","unstructured":"Shuai K, Liu B (2005) Regulation of gene-activation pathways by PIAS proteins in the immune system. Nat Rev Immunol 5(8):593\u2013605","journal-title":"Nat Rev Immunol"},{"issue":"10","key":"2752_CR12","doi-asserted-by":"publisher","first-page":"6083","DOI":"10.1038\/s41380-021-01207-w","volume":"26","author":"J Magalhaes","year":"2021","unstructured":"Magalhaes J et al (2021) PIAS2-mediated Blockade of IFN-beta signaling: a basis for sporadic Parkinson disease dementia. Mol Psychiatry 26(10):6083\u20136099","journal-title":"Mol Psychiatry"},{"key":"2752_CR13","doi-asserted-by":"publisher","first-page":"659038","DOI":"10.3389\/fimmu.2021.659038","volume":"12","author":"S Ghafouri-Fard","year":"2021","unstructured":"Ghafouri-Fard S et al (2021) Expression analysis of protein inhibitor of activated STAT in inflammatory demyelinating polyradiculoneuropathy. Front Immunol 12:659038","journal-title":"Front Immunol"},{"key":"2752_CR14","doi-asserted-by":"publisher","first-page":"457","DOI":"10.2147\/JIR.S187414","volume":"11","author":"M Taheri","year":"2018","unstructured":"Taheri M et al (2018) Expression analysis of protein inhibitor of activated STAT (PIAS) genes in IFNbeta-treated multiple sclerosis patients. J Inflamm Res 11:457\u2013463","journal-title":"J Inflamm Res"},{"key":"2752_CR15","volume-title":"Adams and Victor\u2019s principles of neurology, 12e","author":"AH Ropper","year":"2023","unstructured":"Ropper AH et al (2023) Adams and Victor\u2019s principles of neurology, 12e. McGraw-Hill Education, New York, NY"},{"key":"2752_CR16","doi-asserted-by":"publisher","DOI":"10.1201\/9780429258411","volume-title":"Bayesian data analysis","author":"A Gelman","year":"1995","unstructured":"Gelman A et al (1995) Bayesian data analysis. Chapman and Hall\/CRC"},{"issue":"2","key":"2752_CR17","doi-asserted-by":"publisher","first-page":"99","DOI":"10.20982\/tqmp.14.2.p099","volume":"14","author":"C Muth","year":"2018","unstructured":"Muth C, Oravecz Z, Gabry J (2018) User-friendly bayesian regression modeling: A tutorial with Rstanarm and Shinystan. Quant Methods Psychol 14(2):99\u2013119","journal-title":"Quant Methods Psychol"},{"issue":"12","key":"2752_CR18","doi-asserted-by":"publisher","first-page":"2561","DOI":"10.1007\/s00018-003-3129-1","volume":"60","author":"D Schmidt","year":"2003","unstructured":"Schmidt D, M\u00fcller S (2003) PIAS\/SUMO: new partners in transcriptional regulation. Cell Mol Life Sci 60(12):2561\u20132574","journal-title":"Cell Mol Life Sci"},{"issue":"1","key":"2752_CR19","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1186\/s40001-024-01795-7","volume":"29","author":"Q Zhang","year":"2024","unstructured":"Zhang Q et al (2024) Integrative analysis revealed a correlation of PIAS family genes expression with prognosis, Immunomodulation and chemotherapy. Eur J Med Res 29(1):195","journal-title":"Eur J Med Res"},{"issue":"2","key":"2752_CR20","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3233\/NIB-180141","volume":"7","author":"MM Eftekharian","year":"2018","unstructured":"Eftekharian MM et al (2018) Expression analysis of protein inhibitor of activated STAT (PIAS) genes in autistic patients. Adv Neuroimmune Biology 7(2):129\u2013134","journal-title":"Adv Neuroimmune Biology"},{"issue":"6","key":"2752_CR21","doi-asserted-by":"publisher","first-page":"3203","DOI":"10.1073\/pnas.051489598","volume":"98","author":"B Liu","year":"2001","unstructured":"Liu B et al (2001) A transcriptional corepressor of Stat1 with an essential LXXLL signature motif. Proc Natl Acad Sci U S A 98(6):3203\u20133207","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2752_CR22","doi-asserted-by":"publisher","first-page":"e23931","DOI":"10.4161\/jkst.23931","volume":"2","author":"N Au-Yeung","year":"2013","unstructured":"Au-Yeung N, Mandhana R, Horvath C (2013) Transcriptional regulation by STAT1 and STAT2 in the interferon JAK-STAT pathway. JAK-STAT 2:e23931","journal-title":"JAK-STAT"},{"issue":"1","key":"2752_CR23","doi-asserted-by":"publisher","first-page":"2","DOI":"10.2174\/187152411794961077","volume":"11","author":"FH Ebner","year":"2011","unstructured":"Ebner FH et al (2011) Use of STAT1 inhibitors in the treatment of brain I\/R injury and neurodegenerative diseases. Cent Nerv Syst Agents Med Chem 11(1):2\u20137","journal-title":"Cent Nerv Syst Agents Med Chem"},{"key":"2752_CR24","doi-asserted-by":"crossref","unstructured":"Imitola J et al (2023) Stat1 is an inducible transcriptional repressor of neural stem cells self-renewal program during neuroinflammation. Front Cell Neurosci, 17:1156802","DOI":"10.3389\/fncel.2023.1156802"},{"issue":"1\u20133","key":"2752_CR25","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.febslet.2004.05.081","volume":"570","author":"J Zhang","year":"2004","unstructured":"Zhang J et al (2004) PIASy represses TRIF-induced ISRE and NF-kappaB activation but not apoptosis. FEBS Lett 570(1\u20133):97\u2013101","journal-title":"FEBS Lett"},{"key":"2752_CR26","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.01231-20","author":"J Wang","year":"2020","unstructured":"Wang J et al (2020) IRF1 promotes the innate immune response to viral infection by enhancing the activation of IRF3. J Virol 94(22). https:\/\/doi.org\/10.1128\/jvi.01231-20","journal-title":"J Virol"},{"key":"2752_CR27","doi-asserted-by":"crossref","unstructured":"Zheng W et al (2023) How the innate immune DNA sensing cGAS-STING pathway is involved in apoptosis. Int J Mol Sci, 24(3):3029","DOI":"10.3390\/ijms24033029"},{"issue":"15","key":"2752_CR28","doi-asserted-by":"publisher","first-page":"e2118819119","DOI":"10.1073\/pnas.2118819119","volume":"119","author":"JT Hinkle","year":"2022","unstructured":"Hinkle JT et al (2022) STING mediates neurodegeneration and neuroinflammation in nigrostriatal \u03b1-synucleinopathy. Proc Natl Acad Sci U S A 119(15):e2118819119","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"17","key":"2752_CR29","doi-asserted-by":"publisher","first-page":"9791","DOI":"10.1073\/pnas.1733973100","volume":"100","author":"J Long","year":"2003","unstructured":"Long J et al (2003) Repression of Smad transcriptional activity by PIASy, an inhibitor of activated STAT. Proc Natl Acad Sci U S A 100(17):9791\u20139796","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2752_CR30","doi-asserted-by":"crossref","unstructured":"Mu\u00f1oz MD, de la Fuente N, S\u00e1nchez-Capelo A (2020) TGF-\u03b2\/Smad3 Signalling Modulates GABA Neurotransmission: Implications in Parkinson\u2019s Disease. Int J Mol Sci, 21(2):590","DOI":"10.3390\/ijms21020590"},{"issue":"17","key":"2752_CR31","doi-asserted-by":"publisher","first-page":"4584","DOI":"10.1523\/JNEUROSCI.2952-16.2017","volume":"37","author":"I Tesseur","year":"2017","unstructured":"Tesseur I et al (2017) Deficiency in neuronal TGF-\u03b2 signaling leads to nigrostriatal degeneration and activation of TGF-\u03b2 signaling protects against MPTP neurotoxicity in mice. J Neurosci 37(17):4584\u20134592","journal-title":"J Neurosci"},{"issue":"9","key":"2752_CR32","doi-asserted-by":"publisher","first-page":"4807","DOI":"10.1128\/JVI.03055-15","volume":"90","author":"KL Conn","year":"2016","unstructured":"Conn KL et al (2016) Novel role for protein inhibitor of activated STAT 4 (PIAS4) in the restriction of herpes simplex virus 1 by the cellular intrinsic antiviral immune response. J Virol 90(9):4807\u20134826","journal-title":"J Virol"},{"issue":"28","key":"2752_CR33","doi-asserted-by":"publisher","first-page":"42892","DOI":"10.18632\/oncotarget.9864","volume":"7","author":"L Sun","year":"2016","unstructured":"Sun L et al (2016) Protein inhibitor of activated STAT 4 (PIAS4) regulates pro-inflammatory transcription in hepatocytes by repressing SIRT1. Oncotarget 7(28):42892\u201342903","journal-title":"Oncotarget"},{"issue":"6","key":"2752_CR34","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.14336\/AD.2020.0216","volume":"11","author":"X Li","year":"2020","unstructured":"Li X et al (2020) The critical role of SIRT1 in Parkinson\u2019s disease: mechanism and therapeutic considerations. Aging Dis 11(6):1608\u20131622","journal-title":"Aging Dis"},{"issue":"2","key":"2752_CR35","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/S0165-5728(01)00306-X","volume":"116","author":"B Andorfer","year":"2001","unstructured":"Andorfer B et al (2001) Expression and distribution of transcription factor NF-kappaB and inhibitor IkappaB in the inflamed peripheral nervous system. J Neuroimmunol 116(2):226\u2013232","journal-title":"J Neuroimmunol"},{"issue":"1","key":"2752_CR36","doi-asserted-by":"publisher","first-page":"11","DOI":"10.2174\/1389202914666131210213042","volume":"15","author":"J Dorszewska","year":"2014","unstructured":"Dorszewska J et al (2014) Molecular effects of L-dopa therapy in Parkinson\u2019s disease. Curr Genomics 15(1):11\u201317","journal-title":"Curr Genomics"},{"issue":"1","key":"2752_CR37","doi-asserted-by":"publisher","first-page":"2","DOI":"10.31083\/j.jin2301002","volume":"23","author":"X Chen","year":"2024","unstructured":"Chen X et al (2024) Levodopa improves behavioral deficits of mice with Parkinson\u2019s disease symptoms via curbing NLRP3 inflammasome activation and enhancing tyrosine hydroxylase levels in the striatum and substantia Nigra. J Integr Neurosci 23(1):2","journal-title":"J Integr Neurosci"},{"key":"2752_CR38","doi-asserted-by":"crossref","unstructured":"Sciarra F et al (2023) Gender-Specific impact of sex hormones on the immune system. Int J Mol Sci, 24(7):6302","DOI":"10.3390\/ijms24076302"},{"issue":"4","key":"2752_CR39","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1093\/humupd\/dmi008","volume":"11","author":"A Bouman","year":"2005","unstructured":"Bouman A, Heineman MJ, Faas MM (2005) Sex hormones and the immune response in humans. Hum Reprod Update 11(4):411\u2013423","journal-title":"Hum Reprod Update"},{"key":"2752_CR40","doi-asserted-by":"crossref","unstructured":"Saul D, Kosinsky RL (2021) Epigenetics of aging and aging-Associated diseases. Int J Mol Sci, 22(1):401","DOI":"10.3390\/ijms22010401"},{"key":"2752_CR41","doi-asserted-by":"publisher","first-page":"197","DOI":"10.3389\/fimmu.2018.00197","volume":"9","author":"MG Jasiulionis","year":"2018","unstructured":"Jasiulionis MG (2018) Abnormal epigenetic regulation of immune system during aging. Front Immunol 9:197","journal-title":"Front Immunol"},{"issue":"19","key":"2752_CR42","doi-asserted-by":"publisher","first-page":"16993","DOI":"10.1074\/jbc.M109217200","volume":"277","author":"JA Tan","year":"2002","unstructured":"Tan JA et al (2002) Protein inhibitors of activated STAT resemble scaffold attachment factors and function as interacting nuclear receptor coregulators. J Biol Chem 277(19):16993\u201317001","journal-title":"J Biol Chem"},{"issue":"28","key":"2752_CR43","doi-asserted-by":"publisher","first-page":"11643","DOI":"10.1073\/pnas.0701877104","volume":"104","author":"S Tahk","year":"2007","unstructured":"Tahk S et al (2007) Control of specificity and magnitude of NF-kappa B and STAT1-mediated gene activation through PIASy and PIAS1 Cooperation. Proc Natl Acad Sci U S A 104(28):11643\u201311648","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Acta Neurologica Belgica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13760-025-02752-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13760-025-02752-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13760-025-02752-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T06:14:26Z","timestamp":1748672066000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13760-025-02752-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,28]]},"references-count":43,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["2752"],"URL":"https:\/\/doi.org\/10.1007\/s13760-025-02752-9","relation":{},"ISSN":["0300-9009","2240-2993"],"issn-type":[{"value":"0300-9009","type":"print"},{"value":"2240-2993","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,28]]},"assertion":[{"value":"3 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The present study was performed according to the ethical standards of the institutional and\/or national research committee (INRC) and the 1964 Helsinki declaration and its later amendments. The study protocol was approved by the Ethical Committee of Hamadan University of Medical Sciences (IR.UMSHA.REC.1402.625). The protocols were done in accordance with the relevant guidelines and regulations. Informed consent forms were obtained from all participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}